PNRC2
Proline-rich nuclear receptor coactivator 2
Also known as: PNRC2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPJ4
- Gene
- PNRC2
- Ensembl
- ENSG00000189266
- Chromosome
- 1
- Canonical length
- 139 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
Involved in nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Located in Golgi apparatus; P-body; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
139 residues, UniProt reviewed canonical sequence.
>Q9NPJ4|PNRC2
1 MGGGERYNIP APQSRNVSKN QQQLNRQKTK EQNSQMKIVH KKKERGHGYN SSAAAWQAMQ
61 NGGKNKNFPN NQSWNSSLSG PRLLFKSQAN QNYAGAKFSE PPSPSVLPKP PSHWVPVSFN
121 PSDKEIMTFQ LKTLLKVQVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNRC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 133 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 133 nTPM
- lymph node: 128 nTPM
- thymus: 124 nTPM
- thyroid gland: 114 nTPM
- tonsil: 103 nTPM
- placenta: 97 nTPM
Single-cell type
- epididymal basal cells: 331 nCPM
- esophageal apical cells: 208 nCPM
- fallopian secretory cells: 205 nCPM
- parietal cells: 191 nCPM
- epididymal clear cells: 186 nCPM
- endometrial secretory cells: 177 nCPM
Immune cell
- basophil: 233 nTPM
- total PBMC: 180 nTPM
- naive B-cell: 132 nTPM
- T-reg: 130 nTPM
- memory B-cell: 130 nTPM
- eosinophil: 128 nTPM
Brain region
- white matter: 60 nTPM
- choroid plexus: 58 nTPM
- cerebellum: 55 nTPM
- medulla oblongata: 52 nTPM
- pons: 52 nTPM
- hypothalamus: 49 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- deadenylation-independent decapping of nuclear-transcribed mRNA
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PNRC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNRC2 as an antibody target. Whether an autoantibody or antibody against PNRC2 could matter depends on whether native PNRC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNRC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PNRC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...